The Impact of Once-Monthly Paliperidone Palmitate on Healthcare Utilization Among Patients With Schizophrenia Treated in an Integrated Healthcare System: A Retrospective Mirror-Image Study

INTRODUCTION: Previous evidence demonstrated that patients with schizophrenia consumed substantial healthcare resources in an integrated healthcare system. This study evaluated the impact of initiating once-monthly paliperidone palmitate (PP1M) on healthcare resource utilization (HRU) among patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahabaleshwarkar, Rohan, Lin, Dee, Fishman, Jesse, Blair, Todd, Hetherington, Timothy, Palmer, Pooja, Patel, Charmi, Benson, Carmela, Joshi, Kruti, Krull, Constance, Tcheremissine, Oleg V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948675/
https://www.ncbi.nlm.nih.gov/pubmed/33704681
http://dx.doi.org/10.1007/s12325-021-01626-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948675/
https://www.ncbi.nlm.nih.gov/pubmed/33704681
http://dx.doi.org/10.1007/s12325-021-01626-9

Ejemplares similares